FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Teva North America Linezolid Injection Recall

Linezolid Injection, 600 mg/300 mL Single use container bags (NDC 0703-9060-31), packag…

Teva North America · Horsham, PA

Risk level
Class II
Reported by FDA
Jun 1, 2016
Recall ID
D-0868-2016
Check your lot numberHow we source this data

Summary

Teva North America recalled Linezolid Injection starting Apr 27, 2016. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0868-2016 on Jun 1, 2016. Reason: Lack of Assurance of Sterility: Due to potential for leaking bags. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: Due to potential for leaking bags.

Product description

Linezolid Injection, 600 mg/300 mL Single use container bags (NDC 0703-9060-31), packaged in 10 x 300 mL Single Use Container bags per Box Pack (NDC 0703-9060-33), Rx only, Manufactured In Hungary By: Teva Pharmaceutical Works Ltd., Hungary, H-2100 Godollo, Tancsics M. ut 82 Hungary; Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454

Lot numbers, UPCs & expiration codes

Lot # 2520715, Exp Date: 7/17

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0868-2016
Classification
Class II
Status
Terminated
Recall initiated
Apr 27, 2016
FDA report date
Jun 1, 2016
Quantity
546 bags
Recall type
Voluntary: Firm initiated
Recalling firm
Teva North America

Original FDA data

Every field from FDA enforcement report D-0868-2016, exactly as published.

Show all FDA fields
City
Horsham
State
PA
Status
Terminated
Country
United States
Event ID
74180
Address
425 Privet Rd
Code information
Lot # 2520715, Exp Date: 7/17
Postal code
19044-1220
Report date
Jun 1, 2016
Product type
Drugs
Recall number
D-0868-2016
Classification
Class II
Recalling firm
Teva North America
Product quantity
546 bags
Termination date
Feb 5, 2018
Reason for recall
Lack of Assurance of Sterility: Due to potential for leaking bags.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Linezolid Injection, 600 mg/300 mL Single use container bags (NDC 0703-9060-31), packaged in 10 x 300 mL Single Use Container bags per Box Pack (NDC 0703-9060-33), Rx only, Manufactured In Hungary By: Teva Pharmaceutical Works Ltd., Hungary, H-2100 Godollo, Tancsics M. ut 82 Hungary; Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454
Distribution pattern
Nationwide
Recall initiation date
Apr 27, 2016
Initial firm notification
Letter
Center classification date
May 24, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0868-2016, published Jun 1, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls